ATE293953T1 - Alpha-interferon enthaltende hautpflegemittel - Google Patents

Alpha-interferon enthaltende hautpflegemittel

Info

Publication number
ATE293953T1
ATE293953T1 AT01308850T AT01308850T ATE293953T1 AT E293953 T1 ATE293953 T1 AT E293953T1 AT 01308850 T AT01308850 T AT 01308850T AT 01308850 T AT01308850 T AT 01308850T AT E293953 T1 ATE293953 T1 AT E293953T1
Authority
AT
Austria
Prior art keywords
alpha interferon
containing alpha
products containing
skincare products
skincare
Prior art date
Application number
AT01308850T
Other languages
English (en)
Inventor
Jan Marini
Original Assignee
Jan Marini Skin Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jan Marini Skin Res Inc filed Critical Jan Marini Skin Res Inc
Application granted granted Critical
Publication of ATE293953T1 publication Critical patent/ATE293953T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01308850T 2000-11-03 2001-10-18 Alpha-interferon enthaltende hautpflegemittel ATE293953T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/705,319 US6328987B1 (en) 2000-11-03 2000-11-03 Cosmetic skin care compositions containing alpha interferon

Publications (1)

Publication Number Publication Date
ATE293953T1 true ATE293953T1 (de) 2005-05-15

Family

ID=24832930

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01308850T ATE293953T1 (de) 2000-11-03 2001-10-18 Alpha-interferon enthaltende hautpflegemittel

Country Status (4)

Country Link
US (1) US6328987B1 (de)
EP (1) EP1203579B1 (de)
AT (1) ATE293953T1 (de)
DE (1) DE60110342T8 (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050033512A (ko) * 2001-10-05 2005-04-12 프로사이트 코포레이션 펩타이드 구리 착물 및 레티놀, 레티놀 유도체 또는이들의 혼합물을 함유하는 피부 보호 조성물
WO2003047543A1 (en) * 2001-10-05 2003-06-12 Procyte Corporation Methods for the treatment of hyperpigmentation of skin
US6821524B2 (en) 2002-06-03 2004-11-23 Jan Marini Skin Research, Inc. Cosmetic skin care compositions
US20040038864A1 (en) * 2002-06-27 2004-02-26 Per Balschmidt Use of dimethyl sulfone as isotonicity agent
US20060166879A1 (en) * 2002-12-20 2006-07-27 Chakshu Research Inc Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders
US20060172972A1 (en) * 2002-12-20 2006-08-03 Chakshu Research Inc Formulation and method for administration of ophthalmologically active agents
WO2004110366A2 (en) * 2003-05-29 2004-12-23 Sun Pharmaceuticals Corporation Sunscreen composition
DE60325904D1 (de) * 2003-05-30 2009-03-05 Paoli Ambrosi Gianfranco De Kosmetische und/oder pharmazeutische zubereitung eür die behandlung und die prävention von reizungen, entzündungen und hauterythema
US20050226827A1 (en) * 2004-04-09 2005-10-13 Thienna Ho Skin lightening composition
WO2006004787A1 (en) * 2004-06-28 2006-01-12 Procyte Corporation Methods and compositions for preventing and treating hyperpigmentation of skin
US20060040002A1 (en) * 2004-08-17 2006-02-23 Boitano Suzanne M Anti-itch composition
CA2598792A1 (en) 2005-03-02 2006-09-08 Metanomics Gmbh Process for the production of fine chemicals
US20060293228A1 (en) * 2005-06-24 2006-12-28 Bhatnagar Rajendra S Therapeutic compositions and methods using transforming growth factor-beta mimics
US20060293227A1 (en) * 2005-06-24 2006-12-28 Bhatnagar Rajendra S Cosmetic compositions and methods using transforming growth factor-beta mimics
US20090274736A1 (en) * 2006-01-19 2009-11-05 Solazyme Inc. Nutraceutical Compositions From Microalgae And Related Methods of Production And Administration
US20070166266A1 (en) * 2006-01-19 2007-07-19 Solazyme, Inc. Methods and compositions for improving the health and appearance of skin
US8277849B2 (en) 2006-01-19 2012-10-02 Solazyme, Inc. Microalgae-derived compositions for improving the health and appearance of skin
US8298548B2 (en) 2007-07-18 2012-10-30 Solazyme, Inc. Compositions for improving the health and appearance of skin
US8435547B2 (en) * 2006-08-30 2013-05-07 John P. Blass Cream for stimulating mitochondrial activity in the skin
US8927522B2 (en) 2008-10-14 2015-01-06 Solazyme, Inc. Microalgal polysaccharide compositions
WO2010054322A1 (en) 2008-11-07 2010-05-14 Solazyme, Inc. Cosmetic compositions comprising microalgal components
US20100247693A1 (en) * 2009-03-24 2010-09-30 Marini Jan L Cosmetic formulation to treat rosacea telangiectasia
BR112012010272A2 (pt) * 2009-10-30 2019-10-01 Biogenic Innovations Llc métodos de aumento da eficiência de fermentação de um micro-organismo, in vitro para aumento do crescimento de um ou mais micro-organismos probióticos, para aumento do crescimento de um micro-organismo em uma amostra de teste de diagnóstico e de inibição de atividade microbiana ex vivo, e uso de metilsulfonilmetano (msm)
MX353712B (es) 2009-10-30 2018-01-24 Abela Pharmaceuticals Inc Formulaciones de sulfoxido de dimetilo (dmso) y metilsulfonilmetano (msm) para tratar osteoartritis.
LT2782584T (lt) 2011-11-23 2021-09-10 Therapeuticsmd, Inc. Natūralios kombinuotos pakaitinės hormonų terapijos kompozicijos ir gydymas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10471131B2 (en) 2012-01-19 2019-11-12 Hybrid Medical, Llc Topical therapeutic formulations
US9333242B2 (en) 2012-01-19 2016-05-10 Hybrid Medical, Llc Topical therapeutic formulations
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9808654B2 (en) 2013-02-11 2017-11-07 Jan Marini Skin Research Post procedure skin care gel and methods of use thereof
WO2014186395A1 (en) 2013-05-15 2014-11-20 Solazyme, Inc. Cosmetic compositions comprising microalgal oil
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
WO2016090145A2 (en) 2014-12-03 2016-06-09 Mary Kay Inc. Cosmetic compositions
US9572767B2 (en) 2015-05-20 2017-02-21 Jan Marini Skin Research Luminate hand cream
US10034825B2 (en) 2015-07-01 2018-07-31 Jan Marini Skin Research Luminate eye gel
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017019612A1 (en) 2015-07-27 2017-02-02 Mary Kay Inc. Topical skin formulations
EP4289412A3 (de) 2015-07-28 2024-03-06 Mary Kay, Inc. Topische hautformulierungen
US9949913B2 (en) 2016-03-14 2018-04-24 Jan Marini Skin Research Luminate face lotion
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US10596090B2 (en) 2016-05-27 2020-03-24 Jan Marini Skin Research Cosmetic formulation to reduce facial flushing
US10610479B2 (en) 2017-08-07 2020-04-07 Jan Marini Skin Research HYLA3D hyaluronic acid activating lip complex
US10179103B1 (en) 2018-05-16 2019-01-15 Jan Marini Skin Research Anti-cellulite cream
EP4072513A1 (de) 2019-12-10 2022-10-19 Mary Kay, Inc. Pflanzliche kosmetische zusammensetzung zur behandlung der haut
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957734A (en) * 1982-06-14 1990-09-18 Exovir, Inc. Treatment of certain skin malignancies and pre-malignant skin lesions, herpes zoster and psoriasis
US4469228A (en) * 1983-05-31 1984-09-04 Schering Corporation Interferon kit
US4800081A (en) * 1984-04-18 1989-01-24 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
DE3603444A1 (de) * 1986-02-05 1987-08-06 Thomae Gmbh Dr K Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha
US5686489A (en) * 1986-12-23 1997-11-11 Tristrata Technology, Inc. Alpha hydroxyacid esters for skin aging
US5165921A (en) * 1989-01-23 1992-11-24 National Geno Sciences, Inc. Method for treating condyloma acuminatum with interferon
US5968989A (en) * 1991-12-18 1999-10-19 The Salk Institute For Biological Studies Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
US5853755A (en) 1993-07-28 1998-12-29 Pharmaderm Laboratories Ltd. Biphasic multilamellar lipid vesicles
HUP9602024A3 (en) * 1996-07-25 1999-05-28 Toth Sandor Pharmaceutical composition containing aminoacid for external use

Also Published As

Publication number Publication date
EP1203579A1 (de) 2002-05-08
EP1203579B1 (de) 2005-04-27
DE60110342T8 (de) 2006-08-24
DE60110342T2 (de) 2006-01-26
US6328987B1 (en) 2001-12-11
DE60110342D1 (de) 2005-06-02

Similar Documents

Publication Publication Date Title
ATE293953T1 (de) Alpha-interferon enthaltende hautpflegemittel
ATE365534T1 (de) Kosmetische hautpflegezusammensetzungen
ATE262313T1 (de) Kosmetisches mittel enthaltend maulbeerbaumextrakt und retinoide
HUP0101149A2 (hu) Illatfokozó készítmények kozmetikai termékekhez
WO2004012650A3 (fr) Compositions cosmetiques ou dermopharmaceutiques comprenant du kombucha.
ATE252366T1 (de) Ectoin und ectoinderivate als feuchtigkeitsspender in kosmetikprodukten
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
BR0300830A (pt) Composições tópicas anticâncer e métodos de uso destas
MX9201990A (es) Composiciones cosmeticas en forma de gel, transparentes, substancialmente anhidras y barras desodorantes y antitranspirantes que las contienen.
DE60333873D1 (de) Zubereitungen die Lotusextrakte und Methyldonatoren enthalten
AU3227700A (en) Skin sanitizing compositions
MXPA02004933A (es) Composiciones cosmeticas conteniendo extracto de garbanzo y retinoides.
AU3003199A (en) Tourmaline in cosmetic cleansing compositions
ES2149329T3 (es) Composiciones cosmeticas detergentes y utilizaciones.
ES2167852T3 (es) Utilizacion de derivados oxamato como agentes despigmentantes.
ITMI20011022A0 (it) Composizioni farmaceutiche e cosmetiche contro l'invecchiamento cutaneo
NO964238D0 (no) Halofantrin-fri-base for behandling av malaria og blandinger
ES2073125T3 (es) Uso de compuestos de vitamina d para la produccion de una composicion cosmetica y su uso para mejorar las condiciones de la piel.
FR2810540B1 (fr) Nouvelles preparations cosmetiques ou hygieniques sous forme de dispersion
AR027898A1 (es) Composiciones cosmeticas y metodos para aclarar la piel
DE60235132D1 (de) Sojaprodukte enthaltende Zusammensetzungen
DE50210639D1 (de) Riechstoffmischungen mit gesteigerter geruchstärke
MXPA05011953A (es) Composiciones cosmeticas para la piel.
ATE421872T1 (de) Pulegon enthaltende kosmetische hautpflegezusammensetzungen
TW200507880A (en) The composition of cosmetics which contain rhodiola

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties